BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 16729730)

  • 1. Improved lead-finding for kinase targets using high-throughput docking.
    McInnes C
    Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
    Perola E; Walters WP; Charifson PS
    Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening.
    Chuaqui C; Deng Z; Singh J
    J Med Chem; 2005 Jan; 48(1):121-33. PubMed ID: 15634006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening of Src kinase inhibitors.
    Lee K; Kim J; Jeong KW; Lee KW; Lee Y; Song JY; Kim MS; Lee GS; Kim Y
    Bioorg Med Chem; 2009 Apr; 17(8):3152-61. PubMed ID: 19321350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A minimalist approach to fragment-based ligand design using common rings and linkers: application to kinase inhibitors.
    Aronov AM; Bemis GW
    Proteins; 2004 Oct; 57(1):36-50. PubMed ID: 15326593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical assessment of docking programs and scoring functions.
    Warren GL; Andrews CW; Capelli AM; Clarke B; LaLonde J; Lambert MH; Lindvall M; Nevins N; Semus SF; Senger S; Tedesco G; Wall ID; Woolven JM; Peishoff CE; Head MS
    J Med Chem; 2006 Oct; 49(20):5912-31. PubMed ID: 17004707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of kinase inhibitors by high-throughput docking and scoring based on a transferable linear interaction energy model.
    Kolb P; Huang D; Dey F; Caflisch A
    J Med Chem; 2008 Mar; 51(5):1179-88. PubMed ID: 18271520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase.
    Pierce AC; Jacobs M; Stuver-Moody C
    J Med Chem; 2008 Mar; 51(6):1972-5. PubMed ID: 18290603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput virtual screening using quantum mechanical probes: discovery of selective kinase inhibitors.
    Zhou T; Caflisch A
    ChemMedChem; 2010 Jul; 5(7):1007-14. PubMed ID: 20540063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
    Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
    Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor flexibility for large-scale in silico ligand screens: chances and challenges.
    Fischer B; Merlitz H; Wenzel W
    Methods Mol Biol; 2008; 443():353-64. PubMed ID: 18446296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking and scoring in virtual screening for drug discovery: methods and applications.
    Kitchen DB; Decornez H; Furr JR; Bajorath J
    Nat Rev Drug Discov; 2004 Nov; 3(11):935-49. PubMed ID: 15520816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge-based scoring functions in drug design. 1. Developing a target-specific method for kinase-ligand interactions.
    Xue M; Zheng M; Xiong B; Li Y; Jiang H; Shen J
    J Chem Inf Model; 2010 Aug; 50(8):1378-86. PubMed ID: 20681607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimizing false positives in kinase virtual screens.
    Perola E
    Proteins; 2006 Aug; 64(2):422-35. PubMed ID: 16708364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.